Table 3.
Lipoprotein fractions (% of total HDL) | Lipoprotein fractions (mg/dl) | |||
HC Aβ–(n = 49) | HC Aβ+ (n = 21) | HC Aβ–(n = 49) | HC Aβ+ (n = 21) | |
HDL L | 34.3±11.2 | 34.5±9.5 | 24.4±12.6 | 24.6±12.5 |
HDL I | 53.9±7.4 | 54.0±5.5 | 35.5±6.9 | 35.6±8.6 |
HDL S | 11.7±6.8 | 11.5±5.4 | 7.2±3.5 | 7.1±2.4 |
General linear model | ||||
HDL Subdistribution (% of total HDL) | HDL Subdistribution (mg/dl) | |||
p | p | |||
HDL L | 0.72 | 0.91 | ||
HDL I | 0.40 | 0.88 | ||
HDL S | 0.94 | 0.99 |
ANCOVA (analyses were adjusted for sex, age, site, and APOE ɛ4-carrier status) or non-parametric Mann-Whitney U Test were used and regarded as significant when p < 0.05. For HDL S (% and mg/dl), HDL L (mg/dl) and HDL I (mg/dl) non-parametric tests were used. Values are presented as mean±S.D.